Post by Nazim Coskun

Our multicenter study on Tb-161 PSMA therapy in patients with advanced prostate cancer who had already progressed after Lu-177 PSMA treatment has just been published in The Journal of Nuclear Medicine - JNM. 📝 https://lnkd.in/dabwTfJp This collaborative effort across seven nuclear medicine centers in Türkiye provided encouraging results, suggesting that terbium-161 may hold promise as a next-generation theranostic option. Further studies with larger cohorts are certainly needed. Special thanks to Nuriye Ozlem Kucuk for leading the study, to all co-authors Mine Araz, Nalan Alan MD, Ph.D., Kezban Berberoglu, Elif Özdemir, F. Gül Gümüşer, Serkan Kuyumcu, Ceren Sezgin, Özgür Şanlı, Yasemin Sanli, Mehmet Ali Nahit Şendur, Yüksel ÜRÜN for their important contributions, to our medical physics team BİLAL KOVAN, Yasemin Parlak, Türkay Toklu, Alptuğ Özer Yüksel, Aytaç Barış, and to TerThera b.v. and EDH Nükleer Tıp ve Sağlık Hizmetleri, Hasan Ulaş Özcan, Esra Kılıç, Oguz Ergun, Cem Süleyman Kırbaşer for their valuable support.